Cargando…

Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study

OBJECTIVES: Describe the prevalence of substance-related and addictive disorders (SRAD) in adults with intellectual and developmental disabilities (IDD) and compare the sociodemographic and clinical characteristics of adults with IDD and SRAD to those with IDD or SRAD only. DESIGN: Population-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Elizabeth, Balogh, Robert, McGarry, Caitlin, Selick, Avra, Dobranowski, Kristin, Wilton, Andrew S, Lunsky, Yona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020882/
https://www.ncbi.nlm.nih.gov/pubmed/27591020
http://dx.doi.org/10.1136/bmjopen-2016-011638
_version_ 1782453285109628928
author Lin, Elizabeth
Balogh, Robert
McGarry, Caitlin
Selick, Avra
Dobranowski, Kristin
Wilton, Andrew S
Lunsky, Yona
author_facet Lin, Elizabeth
Balogh, Robert
McGarry, Caitlin
Selick, Avra
Dobranowski, Kristin
Wilton, Andrew S
Lunsky, Yona
author_sort Lin, Elizabeth
collection PubMed
description OBJECTIVES: Describe the prevalence of substance-related and addictive disorders (SRAD) in adults with intellectual and developmental disabilities (IDD) and compare the sociodemographic and clinical characteristics of adults with IDD and SRAD to those with IDD or SRAD only. DESIGN: Population-based cohort study (the Health Care Access Research and Development Disabilities (H-CARDD) cohort). SETTING: All legal residents of Ontario, Canada. PARTICIPANTS: 66 484 adults, aged 18–64, with IDD identified through linked provincial health and disability income benefits administrative data from fiscal year 2009. 96 589 adults, aged 18–64, with SRAD but without IDD drawn from the provincial health administrative data. MAIN OUTCOME MEASURES: Sociodemographic (age group, sex, neighbourhood income quintile, rurality) and clinical (psychiatric and chronic disease diagnoses, morbidity) characteristics. RESULTS: The prevalence of SRAD among adults with IDD was 6.4%, considerably higher than many previous reports and also higher than found for adults without IDD in Ontario (3.5%). Among those with both IDD and SRAD, the rate of psychiatric comorbidity was 78.8%, and the proportion with high or very high overall morbidity was 59.5%. The most common psychiatric comorbidities were anxiety disorders (67.6%), followed by affective (44.6%), psychotic (35.8%) and personality disorders (23.5%). These adults also tended to be younger and more likely to live in the poorest neighbourhoods compared with adults with IDD but no SRAD and adults with SRAD but no IDD. CONCLUSIONS: SRAD is a significant concern for adults with IDD. It is associated with high rates of psychiatric and other comorbidities, indicating that care coordination and system navigation may be important concerns. Attention should be paid to increasing the recognition of SRAD among individuals with IDD by both healthcare and social service providers and to improving staff skills in successfully engaging those with both IDD and SRAD.
format Online
Article
Text
id pubmed-5020882
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50208822016-09-20 Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study Lin, Elizabeth Balogh, Robert McGarry, Caitlin Selick, Avra Dobranowski, Kristin Wilton, Andrew S Lunsky, Yona BMJ Open Mental Health OBJECTIVES: Describe the prevalence of substance-related and addictive disorders (SRAD) in adults with intellectual and developmental disabilities (IDD) and compare the sociodemographic and clinical characteristics of adults with IDD and SRAD to those with IDD or SRAD only. DESIGN: Population-based cohort study (the Health Care Access Research and Development Disabilities (H-CARDD) cohort). SETTING: All legal residents of Ontario, Canada. PARTICIPANTS: 66 484 adults, aged 18–64, with IDD identified through linked provincial health and disability income benefits administrative data from fiscal year 2009. 96 589 adults, aged 18–64, with SRAD but without IDD drawn from the provincial health administrative data. MAIN OUTCOME MEASURES: Sociodemographic (age group, sex, neighbourhood income quintile, rurality) and clinical (psychiatric and chronic disease diagnoses, morbidity) characteristics. RESULTS: The prevalence of SRAD among adults with IDD was 6.4%, considerably higher than many previous reports and also higher than found for adults without IDD in Ontario (3.5%). Among those with both IDD and SRAD, the rate of psychiatric comorbidity was 78.8%, and the proportion with high or very high overall morbidity was 59.5%. The most common psychiatric comorbidities were anxiety disorders (67.6%), followed by affective (44.6%), psychotic (35.8%) and personality disorders (23.5%). These adults also tended to be younger and more likely to live in the poorest neighbourhoods compared with adults with IDD but no SRAD and adults with SRAD but no IDD. CONCLUSIONS: SRAD is a significant concern for adults with IDD. It is associated with high rates of psychiatric and other comorbidities, indicating that care coordination and system navigation may be important concerns. Attention should be paid to increasing the recognition of SRAD among individuals with IDD by both healthcare and social service providers and to improving staff skills in successfully engaging those with both IDD and SRAD. BMJ Publishing Group 2016-09-02 /pmc/articles/PMC5020882/ /pubmed/27591020 http://dx.doi.org/10.1136/bmjopen-2016-011638 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Mental Health
Lin, Elizabeth
Balogh, Robert
McGarry, Caitlin
Selick, Avra
Dobranowski, Kristin
Wilton, Andrew S
Lunsky, Yona
Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
title Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
title_full Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
title_fullStr Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
title_full_unstemmed Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
title_short Substance-related and addictive disorders among adults with intellectual and developmental disabilities (IDD): an Ontario population cohort study
title_sort substance-related and addictive disorders among adults with intellectual and developmental disabilities (idd): an ontario population cohort study
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020882/
https://www.ncbi.nlm.nih.gov/pubmed/27591020
http://dx.doi.org/10.1136/bmjopen-2016-011638
work_keys_str_mv AT linelizabeth substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy
AT baloghrobert substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy
AT mcgarrycaitlin substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy
AT selickavra substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy
AT dobranowskikristin substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy
AT wiltonandrews substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy
AT lunskyyona substancerelatedandaddictivedisordersamongadultswithintellectualanddevelopmentaldisabilitiesiddanontariopopulationcohortstudy